Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2V617F myeloproliferative neoplasm patients

Ariel Amaru Calzada(Azienda Ospedaliero Universitaria Ospedali Riuniti), Josée Golay(Azienda Ospedaliero Universitaria Ospedali Riuniti)

Experimental Hematology

October 27, 2012

10.1016/j.exphem.2012.10.013

Cited by 33

Related Papers

The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2V617F myeloproliferative neoplasm cells

|Experimental Hematology|2012|40